Literature DB >> 10479410

Nuclear targeting of mutant Huntingtin increases toxicity.

M F Peters1, F C Nucifora, J Kushi, H C Seaman, J K Cooper, W J Herring, V L Dawson, T M Dawson, C A Ross.   

Abstract

Huntington's disease is a neurodegenerative disorder resulting from expansion of the polyglutamine region in huntingtin. Although huntingtin is normally cytoplasmic, in affected brain regions proteolytic fragments of mutant huntingtin containing the polyglutamine repeat form intranuclear inclusions. Here, we examine the contribution of nuclear localization to toxicity by transiently transfecting neuro-2a cells with an N-terminal huntingtin fragment similar in size to that believed to be present in patients. The huntingtin fragment, HD-N63, was targeted either to the cytoplasm with a nuclear export signal (NES) or to the nucleus with a nuclear localization signal (NLS). The NES decreased the number of cells with aggregates in the nucleus while an NLS had the opposite effect. By cotransfecting HD-N63 with GFP as a marker, we observed direct cell loss with constructs containing expanded polyglutamine repeats. Compared to unmodified HD-N63-75Q, adding an NES reduced cell loss by 57% while an NLS increased cell loss by 111%. These results indicate that nuclear localization of mutant huntingtin fragments plays an important role in cell toxicity. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10479410     DOI: 10.1006/mcne.1999.0773

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  48 in total

1.  Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy.

Authors:  Natalia B Nedelsky; Maria Pennuto; Rebecca B Smith; Isabella Palazzolo; Jennifer Moore; Zhiping Nie; Geoffrey Neale; J Paul Taylor
Journal:  Neuron       Date:  2010-09-23       Impact factor: 17.173

2.  Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation.

Authors:  Atsushi Iwata; John C Christianson; Mirella Bucci; Lisa M Ellerby; Nobuyuki Nukina; Lysia S Forno; Ron R Kopito
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

Review 3.  Molecular pathogenesis of spinocerebellar ataxia type 6.

Authors:  Holly B Kordasiewicz; Christopher M Gomez
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

Review 4.  The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.

Authors:  Julie Leegwater-Kim; Jang-Ho J Cha
Journal:  NeuroRx       Date:  2004-01

5.  Transgenic mouse model expressing the caspase 6 fragment of mutant huntingtin.

Authors:  Elaine Waldron-Roby; Tamara Ratovitski; XiaoFang Wang; Mali Jiang; Erin Watkin; Nikolas Arbez; Rona K Graham; Michael R Hayden; Zhipeng Hou; Susumu Mori; Deborah Swing; Mikhail Pletnikov; Wenzhen Duan; Lino Tessarollo; Christopher A Ross
Journal:  J Neurosci       Date:  2012-01-04       Impact factor: 6.167

6.  Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death.

Authors:  J A Parker; J B Connolly; C Wellington; M Hayden; J Dausset; C Neri
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

Review 7.  Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy.

Authors:  Jason P Chua; Andrew P Lieberman
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-12       Impact factor: 4.388

Review 8.  Invertebrate models of neurologic disease: insights into pathogenesis and therapy.

Authors:  Leslie Michels Thompson; J Lawrence Marsh
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

9.  Intrabodies binding the proline-rich domains of mutant huntingtin increase its turnover and reduce neurotoxicity.

Authors:  Amber L Southwell; Ali Khoshnan; Denise E Dunn; Charles W Bugg; Donald C Lo; Paul H Patterson
Journal:  J Neurosci       Date:  2008-09-03       Impact factor: 6.167

Review 10.  Nuclear accumulation of polyglutamine disease proteins and neuropathology.

Authors:  Lauren S Havel; Shihua Li; Xiao-Jiang Li
Journal:  Mol Brain       Date:  2009-07-03       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.